TDRL-551

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

TDRL-551 

TDRL-551 是一种有效的复制蛋白A (RPA) 抑制剂 (IC50=18 µM)。TDRL-551 抑制 RPA-DNA 相互作用,提高以铂为基础的肺癌和卵巢癌化疗的疗效。RPA 在核苷酸切除修复 (NER) 和同源重组 (HR) 中起着至关重要的作用,在 DNA 复制和 DNA 损伤检查点激活中也起着重要作用。

TDRL-551

TDRL-551 Chemical Structure

CAS No. : 1644626-43-6

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

TDRL-551 is a potent replication protein A (RPA) inhibitor (IC50=18 µM). TDRL-551 inhibits RPA-DNA interaction and increases the efficacy of Platinum (Pt)-based chemotherapy in lung and ovarian cancer. RPA plays essential roles in both nucleotide excision repair (NER) and homologous recombination (HR), along with its role in DNA replication and DNA damage checkpoint activation[1].

分子量

591.83

Formula

C25H23ClIN3O4

CAS 号

1644626-43-6

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Mishra AK, et al. Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer. Biochem Pharmacol. 2015;93(1):25-33.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务